Abstract Botulinum neurotoxins (BoNT) are divided into seven toxinotypes based on their immunological properties and each toxinotype contains several subtypes according to their amino acid sequences. Here, we designed a mass spectrometry method able to identify BoNT/A subtypes in complex matrices including crude culture supernatants, food, and environmental samples. Peptides from BoNT light chain (L) specific to the subtypes BoNT/A1 to A3 and BoNT/A5 to A8 were identified. The method consists of an immunocapture step with antibodies specific to BoNT/A L chains followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on a triple quadrupole mass spectrometer (QqQ) in multiple reaction monitoring (MRM) mode. BoNT/A subtypes were correctly identified in culture supernatants and in tap water or orange juice samples with a limit of detection of 20 to 150 mouse lethal doses (MLD) and with a lower sensitivity in serum samples.
Introduction
Botulinum neurotoxins (BoNTs) are the most potent toxins and are responsible for a severe paralytic disease, botulism, in man and animals. Most often, botulism occurs subsequently to the ingestion of food contaminated with Clostridium botulinum and containing preformed BoNT. The toxin is absorbed from the intestine and reaches the neuromuscular junction via the blood or lymph circulation and the interstitial fluid. BoNTs act at the neuromuscular junction by inhibiting the evoked release of acetylcholine, thus leading to paralytic symptoms including blurred vision, ptosis, dry mouth, and difficulty in swallowing, then descending into flaccid paralysis of voluntary muscles and respiratory insufficiency [1] [2] [3] .
BoNTs are divided into seven toxinotypes (A to G) based on their immunological properties using the mouse biological test and specific neutralizing antisera [4, 5] . BoNT genes have been sequenced from a large number of strains and sequence comparison has permitted sequence variations in each toxinotype to be identified. Thereby, botulinum toxinotypes are divided into an increased number of subtypes [6] [7] [8] . Five BoNT/A subtypes (A1 to A5) have been identified and recently three additional subtypes (A6 to A8) have been reported [9] [10] [11] (GenBank FJ981696, JQ954969, KF667385, respectively). The significance of sequence variation in each toxinotype is not yet fully recognized, but impacts the diagnostic tests and development of therapeutic agents such as those based on immunotherapy as previously discussed [12] . Antigenic differences have been found between BoNT/As produced by C. botulinum A strains isolated from infant botulism and food-borne botulism [13] . Thereby, BoNT/A1 and BoNT/A2, which differ by 10 % at the amino acid sequence level, show large differences in monoclonal antibody-binding affinity. Among six monoclonal antibodies, which bind to BoNT/A1 with high affinity, three show a marked decrease in binding affinity (500-to more than 1000-fold) towards BoNT/A2 [14] . Therefore, in vivo neutralization of a BoNT toxinotype including the intra-toxinotype variants requires combinations of monoclonal antibodies which tightly bind and potently neutralize each subtype. Thereby, an combination of three monoclonal antibodies with high affinity binding towards subtypes A1 and A2 will completely neutralize A1 or A2 toxin, whereas replacement of two of the three monoclonal antibodies by two having a low binding affinity toward BoNT/A2 induces a decrease in BoNT/A2 neutralization (50-fold less) [15] . Sequence variation among subtypes might also affect the toxin activity and subsequently the course of the disease. The enzymatic site of BoNT/A3 and BoNT/A4 light (L) chain is conserved, but non-conservative mutations in domains involved in substrate (SNAP-25) recognition result in different activity [14] . Although L chains from subtypes A1 to A4 bind to the substrate SNAP25 with similar affinity, L chains from subtype A4 and, to a lesser extent, subtype A3 cleave SNAP25 less efficiently than L chain subtypes A1 and A2 do (two-and 23-fold less, respectively) [16, 17] . BoNT/A1 to A5 exhibit distinct in vitro catalytic activity as well as different biological activity in neuronal cell and mouse models [18] . BoNT/A2 enters neuronal cells faster than BoNT/A1 and it is more potent [19] . In addition, BoNT/A2 is a more potent inhibitor of neurotransmission at the neuromuscular junction [20] . However, both toxins have comparable duration of action [21] . BoNT sequence variations also affect protection by vaccination. As tested in mouse with subtypes A1, A2, and A3, whole BoNT or subunit vaccine based on C-terminal H half part induce efficient homologous protection but variable cross-protection according to the subtype [22] . Development of vaccines and neutralizing antibodies against all the subtypes is a major issue in prevention/treatment of botulism. The recent controversy about the reported new BoNT type H, later referred to as a new hybrid F/A, is mainly based on the existence or absence of cross protection with the already known BoNT types and subtypes, and further raises the importance of subtype determination [23] [24] [25] .
Subtype identification is usually performed via PCR amplification of bont genes and subsequent DNA sequencing [6, 26] . This method requires the presence of the toxigenic strain in the samples and optimally strain isolation and DNA extraction. However, certain samples might contain BoNT in the absence of the bacterium, thus making the use of traditional DNA-based methods impossible. Mass spectrometry (MS) methods have been developed to detect active BoNTs through peptide identification from substrate cleavage (Endopep-MS) (review in [27] ). Endopep-MS is a sensitive method to detect BoNT types, but it cannot identify the toxin subtypes, because all the subtypes of each type recognize the same cleavage site. Tryptic digestion of the toxin itself and analysis of tryptic peptides by MS might allow subtype determination. Thereby, BoNT/A1 and BoNT/A2 have been identified in spiked milk samples on the basis of differential peptides between the two subtypes [28] . A similar approach has been described to differentiate the subtypes of BoNT/B [29] . A multiple enzyme and sequential in-gel digestion approach (MESID) has been proposed for BoNT subtyping. The multiple proteolytic enzymes used in this method facilitate near-complete sequence coverage of all seven BoNT toxinotypes [30] .
Here, we report a method for subtyping BoNT/A in culture supernatants or biological and food samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on a triple quadrupole mass spectrometer (QqQ) in multiple reaction monitoring (MRM) mode.
Experimental Safety considerations
BoNTs have been handled with strict respect to safety rules for the handling of toxic substances.
Materials and chemicals
C. botulinum strains used in this study are listed in Table 1 . C. botulinum strains were grown in trypticase-glucose-yeast extract medium in anaerobic conditions for 4 days. Culture supernatants were stored at −80°C until use. The presence of toxin in the supernatant was first detected by an immunochromatographic test (BTA Gold Assay. NBC-Sys, France) and the toxin activity (MDL 100 mL −1 ) was then tested by a mouse bioassay as previously described [31] . All the peptides used were provided by Proteogenix (France) with purity greater than 95 %. The lyophilized peptides were suspended in H 2 O/HPLC-grade acetonitrile (ACN) 50:50 (v/v) at a concentration of 1 mg mL −1 and stored at −20°C.
A rabbit anti-peptides polyclonal antibody (anti-peptides PAb) was specifically generated by Proteogenix for the immunomagnetic separation. Two peptides, viz. Q67-K84 (DTFTNPEEGDLNPPPEAK) from light chain (Lc) were selected for the immunization. The peptide Q67-K84 is common to the subtypes A1, A2, A3, A5, A6, A7, and A8. The peptide D49-K66 is present in all subtypes, but shows one mutation in the A7 subtype (I50 to T) and in the A8 subtype (K55 to E). Despite these mutations, the two peptides were recognized by the anti-peptides PAb. The reactivity of the anti-peptides PAb with the BoNT/A1, A2, A3, A5, A7, and A8 was checked by ELISA procedure (data not shown). The absence of crossreactivity against BoNT/A heavy chain (Hc), BoNT/B, and BoNT/E was tested by Western blot (data not shown).
The food and environmental samples were from local sources (local tap water), local grocery (orange juice), and French Defense Health Service (human serum).
Animals and ethics statement
Approval was obtained from the ethics committee of DGA Maîtrise NRBC. BALB/C mice (female, 4 weeks old) were purchased from Charles River. The animals were fed with standard diet and water ad libitum. Severely injured mice were euthanized. Determination of mouse lethal dose (MLD 100 ) was performed as previously described [32] . Briefly, 0.5 mL of serial 10-fold and then twofold dilutions of samples in phosphate buffer (50 mM, pH 6.3) containing 0.2 % gelatin were injected intraperitoneally (three mice per dilution). The mice were observed up to 4 days.
Preparation of anti-peptides PAb coated magnetic beads
Protein G-conjugated magnetic beads (Dynabeads Protein G, Novex) (250 μL) were transferred to a 2-mL Eppendorf low binding microcentrifuge tube and were washed three times with 500 μL of PBST (phosphate buffer salt, 0.1 % Tween 20). After the final solution wash was removed, the beads were suspended in 500 μ L of PBST containing 100 μg mL −1 anti-peptides PAb. The mixture was incubated for 30 min with rotation at laboratory temperature. The beads were washed three times with 1 mL of PBS containing 0.15 M NaCl. Antibodies were cross-linked to the beads by incubating in 1250 μL of PBS containing 0.15 M NaCl and 5 mM BS 3 (cross-linking reagent) for 30 min with rotation at laboratory temperature. Then 65 μL of Tris/HCl 1 M pH 7.5 was added to quench the cross-linking reaction. After incubation for 15 min at laboratory temperature with rotation, the beads were washed three times with 1 mL of PBST and resuspended in 250 μL of PBST. They were stored at 4°C for as long as 3 weeks.
In-gel digestion
Each culture supernatant of distinct C. botulinum strains from BoNT subtype was precipitated with 60 % of ammonium sulfate. After precipitation, the pellet was dissolved in 50 mM sodium citrate buffer pH 5.5 and dialyzed overnight at 4°C against the same buffer. The dialyzed sample was fractionated via molecular size chromatography [33] ) at 4°C for 45 min and 2 h at 37°C. Tryptic peptides were extracted from the gel in three successive steps (15 min each), using two cycles of 5 % formic acid, and then 100 % ACN extraction solutions. After drying by vacuum centrifugation, tryptic peptides were resuspended in 20 μL of 1 % TFA before LC-ESI-MS/MS analysis.
Immunocapture enrichment and trypsin digestion
Culture supernatants or samples, crude or diluted in PBS, in a volume of 500 μL were treated with beta-mercaptoethanol (35 μL of 14 M stock solution) for 10 min at 95°C in a dry heating block. After cooling at room temperature, each sample was mixed with 100 μL of PAb-coated magnetic beads in an Eppendorf low binding microcentrifuge tube. The mixture was incubated for 120 min at laboratory temperature with rotation. The beads were then recovered using a magnetic particle concentrator and washed three times with 1 mL of Hepes buffer (pH 7.6, 50 mM). The beads were then suspended in 100 μL of 100 mM ammonium carbonate buffer 
LC-ESI-MS/MS analysis on a ion trap mass spectrometer
LC-ESI-MS/MS analysis was performed on an Esquire 6000 mass spectrometer (ion trap mass spectrometer, Bruker Daltonics, Bremen, Germany) connected to an Ultimate 3000 high-performance liquid chromatograph (Dionex Corp., Sunnyvale, CA). The protein digest (10 μL) was injected on a 0.3×150 mm PepMap100 capillary column, particle size 5 μm, 100 Å pore size (LC Packings, Amsterdam, the Netherlands). Samples were eluted using a gradient starting with a linear increase from 5 to 10 % acetonitrile over 4 min, followed by an increase from 10 to 80 % acetonitrile over 42 min with 0.2 % acid formic throughout as additives. The data acquisition was performed using the data-dependent mode where the three highest-intensity precursors in an MS1 survey scan were selected for collision-induced dissociation (CID). The resulting MS/MS data were searched for protein candidates with a database search against the NCBInr database using MASCOT software (Matrix version 2.2.07, Sciences, London, UK). The mass tolerance of precursor ions and fragment ions was 0.5 Da. Resulting peptides were filtered with a significance threshold of p<0.05.
LC-QqQ-MS/MS analysis in MRM mode
The HPLC system used for this analysis was an Ultimate 3000 RSLC equipped with a degasser, a binary pump, an auto-injector, and a column oven (Thermo Scientific) coupled to a TSQ Quantiva electrospray ionization triple quadrupole mass spectrometer (Thermo Scientific). Chromatographic separations were performed on Zorbax SB-C18 2.1×150 mm, 3.5 μm, 80 Å pore size (Agilent) using 0.2 % (v/v) formic acid as eluent A and acetonitrile with 0.2 % formic acid as eluent B with a flow rate of 200 μL/min at 25°C. Samples (10 μL) were analyzed in a gradient mode: 5 % eluent B (0-2 min) and 50 % B (30 min). The mass spectrometer ESI source was operated in positive ionization mode. The following conditions were applied: spray voltage, 4000 V; sheath gas, 50 Arb; aux gas, 10 Arb; sweep gas, 5 Arb; ion transfer tube temp, 325°C; vaporizer temp, 275°C; CID gas, argon, 2 mTorr.
Food and biological samples
Food and human serum samples were artificially spiked with culture supernatant of each C. botulinum A subtype, and 0.5 mL of each sample was treated as described above for the culture supernatants except that the serum samples were not heated. Serial 10-fold dilutions of each sample were tested by mouse bioassay and by immunocapture/LC-QqQ-MS/MS in MRM mode. 
Results
Selection of specific peptides for detection of botulinum toxin A subtypes MS-based analysis can distinguish proteins on the basis of amino acid sequence. BoNT/A1 to BoNT/A8 subtypes share 84.5 to 97.2 % identity at the amino acid level ( Table 2) . We first identified the trypsic cleavage sites on the sequences of the L chain (amino acids 1 to 449) of each BoNT/A subtype and we then analyzed all the subsequent peptides for their specificity versus the other BoNT/A subtypes by Blast. Thereby, 26 peptides of each BoNT/A subtypes were analyzed in silico. Two to 12 unique peptides for each BoNT/A subtype were synthesized and analyzed in MS full scan and MS/MS to identify predominant product ions (Table 3 ). Then, they were analyzed in LC-QqQ-MS/MS in MRM mode, and for each subtype, two specific peptides yielding the best response were selected. One peptide was common to both BoNT/A2 and BoNT/A8, and two others to BoNT/A1 and BoNT/A6. Moreover, two additional peptides which were conserved in all BoNT/A subtypes were also selected (Table 4) .
To validate the selection of these peptides for the identification of BoNT/A subtypes, BoNT preparations of each subtype (1 to 2 μg) were run on an SDS-PAGE and the bands containing the L chain were cut out of the gel. After in-gel trypsin digestion, the peptides were extracted and analyzed with LC-ESI-MS/MS (data not shown). BoNT/A4 and BoNT/A6 were not included in this study because of the difficulty in obtaining BoNT/A4 preparations containing sufficient amounts of toxin and because BoNT/A6 (strain CDC41370) was not available in our collection. 
Identification of BoNT/A subtype in culture supernatants
To identify BoNT/A subtype in a complex environment like culture supernatant, we used an immunocapture step. For that purpose, magnetic beads were coated with antibodies raised against two synthetic peptides conserved in BoNT/A light chain subtypes as described in the BExperimental^part. Culture supernatant samples (500 μL) were reduced by addition of beta-mercaptoethanol to allow the separation of L and H chains and were then incubated with coated magnetic beads. It is noteworthy that beta-mercaptoethanol facilitated the L chai n capture, since experiment s without betamercaptoethanol pretreatment resulted in lower detection sensitivity. After washing, the bound material was digested by trypsin in situ, dried, and analyzed by LC-MS/MS. An example of conserved peptide detection by LC-MS/MS in culture supernatants of representative strains of each BoNT/A subtype is shown in Fig. 1 . Clostridium sporogenes which is closely related to C. botulinum A strains showed no detectable peptide corresponding to L chain fragment. Figure 2 shows identification of BoNT/A2 through detection of the specific subtype peptide (DVASTLNK) by LC-MS/MS in C. botulinum culture supernatants. The global results of peptide detection in C. botulinum culture supernatants are listed in Table 5 . The selected conserved peptides were detected in all the C. botulinum culture supernatants tested, whereas the selected specific subtype peptides were only identified in the corresponding C. botulinum subtype culture supernatants. However, the I376-K387 peptide was detected in both C. botulinum A2 and A8 subtype culture supernatants, in contrast to the D292-K299 peptide which was only found in C. botulinum A2 strains (Table 5 ).
Sensitivity
The limit of detection (LOD) for subtyping BoNT/A by the LC-QqQ-MS/MS in MRM mode was estimated by using serial dilutions of C. botulinum culture supernatants. LOD corresponded to the highest dilution giving a signal with a signal-to-noise ratio of 3. The results with representative C. botulinum culture supernatant subtypes and expressed in equivalent MLD 100, which have been determined by the mouse bioassay, are shown in Table 6 . The MS methodology could detect BoNT ranging from 20 to 140 MLD/0.5 mL according to the subtype.
Identification of BoNT/A subtype in different matrices
In order to validate the method of LC-QqQ-MS/MS in MRM mode with biological, food, or environmental samples, LOD was determined in various representative matrices (tap water, orange juice, human serum) spiked with the distinct BoNT/A subtypes. As shown in Table 7 , the BoNT/A subtypes A1 to A8 were successfully identified in all the different samples. Using non-inoculated TGY medium as background, the method easily identified BoNT peptides at the LOD as shown in Fig. 3 for BoNT/A2. Note that no interfering peak at the expected retention times was observed in the tap water and orange juice matrices. The best LOD values were obtained with tap water and orange juice and were comparable to those obtained with culture supernatants (Table 6 ), whereas the detection was slightly lower (4-to 10-fold less) in human serum because of a higher background.
Discussion
Detection of BoNT in biological samples and food is critical for early diagnosis of botulism and to apply an efficient treatment of the disease. Investigation of BoNT in food or environmental samples is also essential for identifying the source of contamination and preventing outbreak extension of botulism. Typing and subtyping are important to estimate the severity of the disease and to adapt the appropriate treatmentnotably the specificity of the antisera. The determination of typing and subtyping is also critical in botulism outbreak investigations and to trace the source of intoxication, thereby allowing one to evidence the commonality or difference between strains from patients of a same outbreak or distinct outbreaks, and between strains from patients and suspected food. MS is a rapid and powerful method to identify proteins. Notably, this method allows one to get the results in a few hours from a culture supernatant (about 6 h) instead of a few days with molecular biology techniques which require DNA preparation and sequencing usually via an external platform or company. Here, we show that an LC-QqQ-MS/MS method in MRM mode coupled to an immunopurification step allows the identification of BoNT/A type and subtypes from complex samples. The method based on L chain peptides specific to BoNT/A subtypes A1 to A8 yielded unambiguous identification of the subtypes. A previous MS approach has been designed to differentiate BoNT/A1 and BoNT/A2 [28] . Identification of BoNT types A1 to G was achieved by using a multiple enzyme digestion in gel and subsequent LC-QqQ-MS analysis. This method is predicted to identify the subtypes but has not yet been validated [30] . Our procedure efficiently discriminated the distinct BoNT/A subtypes. One important advantage is that complex samples can be used. Subtyping was efficiently performed with crude culture supernatants. An additional advantage is that this method of subtyping is performed in one step without the need for further techniques or reagents to address the subtyping. However, this method would be tested with complex and naturally contaminated samples like food or stools. LOD of the proposed method (20 to 140 equivalents MLD in 0.5 mL) is in the range of the minimal toxin concentrations found in food. The sensitivity of the method could be increased by using a greater sample volume. Using artificially spiked samples representative of food, environmental, and biological samples, the LC-QqQ-MS method allowed the identification of all the BoNT/A subtypes tested. LOD varied with the matrix, with the highest values in serum samples. Although the proposed method is not sensitive enough to detect limited BoNT amounts, it is appropriate for contaminated environmental or food samples which usually contain significant BoNT concentrations (100 MLD/g and more). The advantage of the LCQqQ-MS approach is to allow subtype identification in the absence of viable neurotoxin-producing bacteria or available DNA in samples to perform a genetic subtyping. Further developments are still required for application with biological samples. It is noteworthy that this methodology might be updated to identify new subtypes that will be evidenced, by selecting additional specific peptides on light and/or heavy chains.
